Live Breaking News & Updates on Compas Scientific Founder
Stay updated with breaking news from Compas scientific founder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
We continue to open clinical sites and enroll patients in COMPANION-002, the Phase 2/3 randomized study of CTX-009 in patients with advanced biliary tract cancer . Consistent with prior guidance, top. ....